RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma
Authors:
- Małgorzata WienchMWMałgorzata Wiench
- Jan WłochJWJan Włoch
- Zbigniew WygodaZWZbigniew Wygoda
- Elżbieta GubałaEGElżbieta Gubała
- M. OczkoMOM. Oczko
- A. PawlaczekAPA. Pawlaczek
- D. KulaDKD. Kula
- D. LangeDLD. Lange
- B. JarzabB. Jarzab
- 1 January 2004
- journal article
- Published by Elsevier in Cancer Detection Prevention
- Vol. 28 (4) , 231-236
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Amplification and Overexpression of Mutant RET in Multiple Endocrine Neoplasia Type 2-Associated Medullary Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 2003
- Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinomaOncogene, 2001
- Estimation of Risk of Inherited Medullary Thyroid Carcinoma in Apparent Sporadic PatientsJournal of Clinical Oncology, 2001
- RET Proto-Oncogene in the Development of Human CancerJournal of Clinical Oncology, 1999
- Association of multiple endocrine neoplasia type 2 and Hirschsprung diseaseJournal of Internal Medicine, 1998
- Oncogenic activation of RET by two distinct FMTC mutations affecting the tyrosine kinase domainOncogene, 1997
- RET mutations in human diseaseTrends in Genetics, 1996
- Mechanism of Activation of the ret Proto-oncogene by Multiple Endocrine Neoplasia 2A MutationsMolecular and Cellular Biology, 1995
- Catalytic specificity of protein-tyrosine kinases is critical for selective signallingNature, 1995
- Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2BScience, 1995